MicroRNA electrochemical biosensors for pancreatic cancer
F Rahdan, F Bina, EN Dolatabadi, D Shaterabadi… - Clinica Chimica …, 2023 - Elsevier
Pancreatic cancer (PC) is one of the deadliest cancers worldwide. MicroRNAs (miRs) are
sensitive molecular diagnostic tools that can serve as highly accurate biomarkers in many …
sensitive molecular diagnostic tools that can serve as highly accurate biomarkers in many …
Recent developments of nanomedicine delivery systems for the treatment of pancreatic cancer
N Rezaei, M Shahriari, F Mehrnejad - Journal of Drug Delivery Science and …, 2023 - Elsevier
Pancreatic cancer (PCa) is one of the principal causes of death from cancer, resulting in a
low patient survival rate due to its late diagnosis. Many factors are involved in the failure of …
low patient survival rate due to its late diagnosis. Many factors are involved in the failure of …
[HTML][HTML] AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor
K Ingle, JF LaComb, LM Graves, AT Baines… - PLoS …, 2023 - journals.plos.org
Pancreatic cancer is one of the leading causes of cancer deaths, with pancreatic ductal
adenocarcinoma (PDAC) being the most common subtype. Advanced stage diagnosis of …
adenocarcinoma (PDAC) being the most common subtype. Advanced stage diagnosis of …
[HTML][HTML] Polyethyleneglycol-Betulinic Acid (PEG-BA) polymer-drug conjugate induces apoptosis and antioxidation in a biological model of pancreatic cancer
Pancreatic cancer (PC) is one of the most aggressive solid malignancies with poor treatment
response and low survival rates. Herbal medicines such as betulinic acid (BA) have shown …
response and low survival rates. Herbal medicines such as betulinic acid (BA) have shown …
[HTML][HTML] Gemcitabine and rapamycin-loaded mixed polymeric thermogel for metastatic pancreatic cancer therapy
SY Kim, MJ Jo, MS Yoon, CE Jin, YB Shin… - Journal of Controlled …, 2023 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is the 4th leading cause of cancer–related death
and has a poor 5–year overall survival. The superior therapeutic benefits of combination or …
and has a poor 5–year overall survival. The superior therapeutic benefits of combination or …
[HTML][HTML] Earlier Diagnosis of Pancreatic Cancer: Is It Possible?
T Koltai - Cancers, 2023 - mdpi.com
Simple Summary Pancreatic cancer incidence is increasing yearly. The reasons are not well
known. Unfortunately, this is one of the least treatable cancers. Standard chemotherapy …
known. Unfortunately, this is one of the least treatable cancers. Standard chemotherapy …
[HTML][HTML] Prognostic evaluation of pancreatic cancer based on the model of chemo-radiotherapy resistance-related genes
H Sun, W Zhang, Y Chu, L Zhou, F Gong… - Journal of …, 2023 - ncbi.nlm.nih.gov
Background The incidence and mortality of pancreatic cancer are almost the same, and the
5-year survival rate is less than 10%. The high mortality of pancreatic cancer is related to …
5-year survival rate is less than 10%. The high mortality of pancreatic cancer is related to …
[HTML][HTML] Glucose Regulation after Partial Pancreatectomy: A Comparison of Pancreaticoduodenectomy and Distal Pancreatectomy in the Short and Long Term
Background Long term quality of life is becoming increasingly crucial as survival following
partial pancreatectomy rises. The purpose of this study was to investigate the difference in …
partial pancreatectomy rises. The purpose of this study was to investigate the difference in …
[HTML][HTML] Systemic diseases and gastrointestinal cancer risk
Importance: Gastrointestinal (GI) cancers are the second leading cause of cancer-related
deaths worldwide. Observations: The global challenges GI cancers pose are high …
deaths worldwide. Observations: The global challenges GI cancers pose are high …
Integrated in silico analysis of proteogenomic and drug targets for pancreatic cancer survival
Pancreatic cancer remains a major health concern, being among the deadliest forms of
cancer with over 80% of the patients presenting with metastatic disease. According to the …
cancer with over 80% of the patients presenting with metastatic disease. According to the …